appConfigEntityId

bodyType

customContents

entityId

entityUuid

isVideo

articlePageQuery

article

articleSchemaContent

content

hooksArticlePageAdvertisementConfigArticle

appConfig

filter

json

liveArticle

Curation Team

1. HIV cure on horizon? Hong Kong firm Immuno Cure unveils promising vaccine, ICVAX
“We may be on the brink of a breakthrough,” the company advisory board chairman said as the biotech start-up reported promising results from clinical trials. The vaccine, designed to be administered after infection, could offer a potential cure for HIV, the virus that causes Aids.
2. Trump tariffs threaten Chinese biotech profits, medical device makers brace for impact
Chinese biotech firms are facing a double whammy of US funding restrictions and tariffs after Trump proposed import duties of 60 to 100 per cent on Chinese goods. Efforts to expand high-value product sales within China and alternative overseas markets outside the US may mitigate the impact.
3. China’s pharmaceutical boom sees market surge past US$13 billion with 113 new drugs since 2021
China’s pharmaceutical industry is booming, with 113 innovative drugs approved since its 14th five-year plan began in 2021, exceeding the previous five-year plan by nearly three times. This surge in innovation has driven the market scale to US$13.8 billion, making China a global leader in drug development.

4. China’s ‘bat lady’ Shi Zhengli and international team conduct groundbreaking research into new coronavirus treatments
China’s leading virologist Shi, best known for her work with the Wuhan Institute for Virology, has developed a revolutionary approach to create custom coronavirus receptors. The work paves the way for new treatments and research into difficult-to-culture viruses and infectious diseases.
5. Henlius, XtalPi expand globally with deals in Saudi Arabia and Indonesia as Chinese drug companies ‘go out’ for growth
The two Chinese pharmaceutical firms have signed new overseas partnerships, leveraging AI and quantum physics to drive innovation and growth. Showcasing China’s tech prowess in drug development, Fosun Group’s Shanghai Henlius Biotech and XtalPi, formerly known as QuantumPharm, are tapping into new growth markets.
Part of this article was produced with the assistance of generative AI.


Xi on North Korean military ties; US blacklists Chinese tech firms: SCMP’s 7 highlights

Tokyo Sézanne’s missing stars; Hongkonger shed 32kg in 8 months: 7 Lifestyle highlights

Chinese carmakers race Tesla on humanoid robots; BYD launches ‘God’s Eye’: 7 EV reads

Philippines’ deadly quake, India’s rise in critical minerals: 7 Asia highlights

SCMP Highlights

‘Promising’ steps to HIV vaccine, Trump tariffs threaten Chinese profits: 5 biotech stories

A Hong Kong biotech start-up says its first-phase trial of a therapeutic HIV vaccine has shown promising results. Photo: dpa


Virologist Shi Zhengli is best known for her research into coronaviruses in Wuhan. Photo: AP

News

China

Discover breakthroughs in the biotech world, from a potential HIV cure to China’s booming drug market and innovative coronavirus treatments, in some of our latest stories


Discover breakthroughs in the biotech world, from a potential HIV cure to China’s booming drug market and innovative coronavirus treatments, in some of our latest stories.


1. .css-jfmysa{display:inline;word-break:break-word;}.css-1ankfgb{cursor:pointer;display:inline;word-break:break-word;}HIV cure on horizon? Hong Kong firm Immuno Cure unveils promising vaccine, ICVAX

2. Trump tariffs threaten Chinese biotech profits, medical device makers brace for impact

1. HIV cure on horizon? Hong Kong firm Immuno Cure unveils promising vaccine, ICVAX